Learning from BISCAY: The future of biomarker-based trial design in bladder cancer. Meza L, Salgia NJ, Patel KC, Pal SK, et al. Cancer Cell 2021;39:910-912.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meza L, Salgia NJ, Patel KC, Pal SK, et al. Learning from BISCAY: The future of biomarker-based trial design in bladder cancer. Cancer Cell 2021;39:910-912.
PMID: 34256907